X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-07-03 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $9.42 | -936 | 40,017 | -2% | -$8,818 | ||||||
2023-06-30 | IGMS | Topsoe Christina Teng | Dir, 10% | P - Purchase | $9.32 | +3,000 | 10,449,807 | 0% | +$27,957 | ||||||
2023-06-29 | IGMS | Redmile Group, LLC | Dir | P - Purchase | $9.42 | +80,423 | 5,948,864 | +1% | +$757,585 | ||||||
2023-06-29 | IGMS | Redmile Group, LLC | Dir | S - Sale | $9.42 | -80,423 | 5,948,864 | -1% | -$757,585 | ||||||
| M | 2023-06-29 | IGMS | Topsoe Jakob Haldor | Dir, 10% | P - Purchase | $9.17 | +7,000 | 10,482,700 | 0% | +$64,222 | |||||
2023-06-26 | IGMS | Behrens M Kathleen | Dir | P - Purchase | $8.00 | +112,500 | 394,881 | +40% | +$900,000 | ||||||
2023-05-23 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $12.31 | -1,259 | 54,742 | -2% | -$15,497 | ||||||
2023-05-23 | IGMS | Tahir Misbah | CFO | S - Sale | $12.31 | -1,259 | 50,711 | -2% | -$15,497 | ||||||
2023-05-23 | IGMS | Schwarzer Fred | CEO, Pres | S - Sale | $12.31 | -1,259 | 318,479 | 0% | -$15,497 | ||||||
2023-05-23 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $12.31 | -982 | 139,071 | -1% | -$12,088 | ||||||
2023-05-23 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $12.31 | -1,259 | 40,953 | -3% | -$15,497 | ||||||
2023-05-23 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $12.31 | -1,259 | 41,181 | -3% | -$15,497 | ||||||
| D | 2023-04-05 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale+OE | $12.60 | -935 | 33,878 | -3% | -$11,781 | |||||
2023-03-14 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $18.73 | -1,768 | 28,789 | -6% | -$33,118 | ||||||
2023-03-14 | IGMS | Tahir Misbah | CFO | S - Sale | $18.73 | -1,768 | 25,322 | -7% | -$33,118 | ||||||
2023-03-14 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $18.73 | -1,293 | 91,717 | -1% | -$24,220 | ||||||
2023-03-14 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $18.73 | -1,061 | 18,563 | -5% | -$19,875 | ||||||
2023-03-14 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $18.73 | -1,061 | 16,732 | -6% | -$19,875 | ||||||
2022-12-16 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $18.98 | -5,430 | 30,557 | -15% | -$103,080 | ||||||
| M | 2022-12-16 | IGMS | Tahir Misbah | CFO | S - Sale | $19.62 | -6,084 | 27,090 | -18% | -$119,359 | |||||
2022-12-16 | IGMS | Schwarzer Fred | CEO, Pres | S - Sale | $18.98 | -12,369 | 217,078 | -5% | -$234,805 | ||||||
2022-12-16 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $18.98 | -5,371 | 59,254 | -8% | -$101,960 | ||||||
2022-12-16 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $18.98 | -4,354 | 19,624 | -18% | -$82,654 | ||||||
2022-12-16 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $18.98 | -2,484 | 17,793 | -12% | -$47,154 | ||||||
2022-11-23 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $21.57 | -877 | 35,987 | -2% | -$18,918 | ||||||
2022-11-23 | IGMS | Tahir Misbah | CFO | S - Sale | $21.57 | -877 | 33,174 | -3% | -$18,918 | ||||||
2022-11-23 | IGMS | Schwarzer Fred | CEO, Pres | S - Sale | $21.57 | -1,258 | 229,447 | -1% | -$27,136 | ||||||
2022-11-23 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $21.57 | -877 | 39,625 | -2% | -$18,918 | ||||||
2022-11-23 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $21.57 | -1,258 | 23,978 | -5% | -$27,136 | ||||||
2022-11-23 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $21.57 | -1,258 | 20,277 | -6% | -$27,136 | ||||||
2022-11-08 | IGMS | Behrens M Kathleen | Dir | P - Purchase | $17.14 | +60,000 | 281,207 | +27% | +$1,028,550 | ||||||
| D | 2022-10-04 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale+OE | $22.84 | -25,000 | 40,502 | -38% | -$570,980 | |||||
2022-09-29 | IGMS | Loberg Michael D | Dir | P - Purchase | $19.62 | +5,821 | 78,981 | +8% | +$114,213 | ||||||
| M | 2022-09-27 | IGMS | Loberg Michael D | Dir | P - Purchase | $20.89 | +6,679 | 72,627 | +10% | +$139,539 | |||||
| DM | 2022-09-06 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale+OE | $19.34 | -25,000 | 40,502 | -38% | -$483,540 | |||||
| DM | 2022-08-18 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale+OE | $22.17 | -25,000 | 40,502 | -38% | -$554,347 | |||||
2022-05-24 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $17.10 | -938 | 36,864 | -2% | -$16,043 | ||||||
2022-05-26 | IGMS | Tahir Misbah | CFO | S - Sale | $17.10 | -950 | 33,698 | -3% | -$16,247 | ||||||
2022-05-24 | IGMS | Schwarzer Fred | CEO, Pres | S - Sale | $17.10 | -1,362 | 230,705 | -1% | -$23,294 | ||||||
2022-05-24 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $17.10 | -939 | 40,502 | -2% | -$16,058 | ||||||
2022-05-24 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $17.10 | -1,340 | 25,236 | -5% | -$22,917 | ||||||
2022-05-24 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $17.10 | -1,362 | 21,535 | -6% | -$23,293 | ||||||
2022-05-20 | IGMS | Topsoe Jakob Haldor | Dir, 10% | P - Purchase | $16.00 | +1,481 | 10,474,026 | 0% | +$23,696 | ||||||
| D | 2022-04-06 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale+OE | $25.00 | -2,500 | 41,028 | -6% | -$62,500 | |||||
2022-04-01 | IGMS | Loberg Michael D | Dir | P - Purchase | $23.00 | +21,739 | 65,415 | +50% | +$499,997 | ||||||
2022-04-01 | IGMS | Behrens M Kathleen | Dir | P - Purchase | $23.00 | +60,869 | 32,452 | -214% | +$1,399,987 | ||||||
| D | 2022-03-30 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale+OE | $28.50 | -7,500 | 41,028 | -15% | -$213,725 | |||||
| D | 2021-11-02 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale+OE | $51.37 | -1,326 | 4,070 | -25% | -$68,117 | |||||
| D | 2021-10-05 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale+OE | $64.10 | -1,242 | 4,070 | -23% | -$79,617 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |